Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells

International Immunology

Volumn 19, Issue 1, 2007, Pages 59-65

  Francés, Rubén ^a,b   Tumang, Joseph R ^a,c   Rothstein, Thomas L ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CALCIUM ION; CALCYCLIN; LIPOCORTIN 2; MESSENGER RNA; MITOGENIC AGENT;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CALCIUM BINDING; CELL SPECIFICITY; CELL STIMULATION; CELL TYPE; CELLULAR DISTRIBUTION; GENE EXPRESSION; LIQUID CHROMATOGRAPHY; LYMPHOCYTE SUBPOPULATION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RELIABILITY; SPLEEN CELL; STRUCTURAL PROTEOMICS; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

ANIMALS; ANNEXIN A2; B-LYMPHOCYTE SUBSETS; CELL CYCLE PROTEINS; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MULTIPROTEIN COMPLEXES; PERITONEUM; PROTEOMICS; S100 PROTEINS;

EID: 33845903559     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl122     Document Type: Article

References (44)

1. Herzenberg, L. A. 2000. B-1 cells: The lineage question revisited. Immunol. Rev. 175:9.
2. Hardy, R. R. and Hayakawa, K. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595.
3. Berland, R. and Wortis, H. H. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20:253.
4. Rothstein, T. L. 2002. Cutting edge commentary: Two B-1 or not to be one. J. Immunol. 168:4257.
5. Briles, D. E., Nahm, M., Schroer, K. et al. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153:694.
6. Boes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C. and Chen, J. 1998. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188:2381.
7. Ochsenbein, A. F., Fehr, T., Lutz, C. et al. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156.
8. Baumgarth, N., Herman, O. C., Jager, G. C., Brown, L. E., Herzenberg, L. A. and Chen, J. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192:271.
9. Haas, K. M., Poe, J. C., Steeber, D. A. and Tedder, T. F. 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23:7.
10. Karras, J. G., Wang, Z., Huo, L., Howard, R. G., Frank, D. A. and Rothstein, T. L. 1997. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes [see comments]. J. Exp. Med. 185:1035.
11. Wong, S. C., Chew, W. K., Tan, J. E., Melendez, A. J., Francis, F. and Lam, K. P. 2002. Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 277:30707.
12. Berland, R. and Wortis, H. H. 2003. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc. Natl Acad. Sci. USA 100:13459.
13. Tumang, J. R., Frances, R., Yeo, S. G. and Rothstein, T. L. 2005. Cutting edge: Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J. Immunol. 174:3173.
14. Tumang, J. R., Hastings, W. D., Bai, C. and Rothstein, T. L. 2004. Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristics. Eur. J. Immunol. 34:2158.
15. Cohen, D. P. and Rothstein, T. L. 1991. Elevated levels of protein kinase C activity and alpha-isoenzyme expression in murine peritoneal B cells. J. Immunol. 146:2921.
16. Sen, G., Wu, H. J., Bikah, G. et al. 2002. Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations. Mol. Immunol. 39:57.
17. Dal Porto, J. M., Burke, K. and Cambier, J. C. 2004. Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck. Immunity 21:443.
18. Kretschmer, K., Jungebloud, A., Stopkowicz, J., Stoermann, B., Hoffmann, R. and Weiss, S. 2003. Antibody repertoire and gene expression profile: implications for different developmental and functional traits of splenic and peritoneal B-1 lymphocytes. J. Immunol. 171:1192.
19. Frances, R., Tumang, J. R., Kaku, H., Gurdak, S. M. and Rothstein, T. L. 2006. B-1 cells express transgelin 2: Unexpected lymphocyte expression of a smooth muscle protein identified by proteomic analysis of peritoneal B-1 cells. Mol. Immunol. 43:2124.
20. Lin, D., Tabb, D. L. and Yates, J. R. III 2003. Large-scale protein identification using mass spectrometry. Biochim. Biophys. Acta 1646:1.
21. Chumley, M. J., Dal Porto, J. M. and Cambier, J. C. 2002. The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen. J. Immunol. 169:1735.
22. Schneider, T. J., Grillot, D., Foote, L. C., Nunez, G. E. and Rothstein, T. L. 1997. Bcl-x protects primary B cells against Fas-mediated apoptosis. J. Immunol. 159:4834.
23. Frances, R., Tumang, J. R. and Rothstein, T. L. 2005. Cutting edge: B-1 cells are deficient in Lck: Defective B cell receptor signal transduction in B-1 cells occurs in the absence of elevated Lck expression. J. Immunol. 175:27.
24. Filipek, A., Gerke, V., Weber, K. and Kuznicki, J. 1991. Characterization of the cell-cycle-regulated protein calcyclin from Ehrlich ascites tumor cells. Identification of two binding proteins obtained by Ca2(+)-dependent affinity chromatography. Eur. J. Biochem. 195:795.
25. Tokumitsu, H., Mizutani, A., Minami, H., Kobayashi, R. and Hidaka, H. 1992. A calcyclin-associated protein is a newly identified member of the Ca2+/phospholipid-binding proteins, annexin family. J. Biol. Chem. 267:8919.
26. Fischer, G. M., Solt, L. A., Hastings, W. D. et al. 2001. Splenic and peritoneal B-1 cells are distinct populations as defined by transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. Cell. Immunol. 213:62.
27. Ansel, K. M., Harris, R. B. and Cyster, J. G. 2002. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16:67.
28. Rand, J. H. 2000. The annexinopathies: A new category of diseases. Biochim. Biophys. Acta 1498:169.
29. Gerke, V. and Moss, S. E. 2002. Annexins: From structure to function. Physiol. Rev. 82:331.
30. Chiang, Y., Davis, R. G. and Vishwanatha, J. K. 1996. Altered expression of annexin II in human B-cell lymphoma cell lines. Biochim. Biophys. Acta 1313:295.
31. Claudio, J. O., Masih-Khan, E., Tang, H. et al. 2002. A molecular compendium of genes expressed in multiple myeloma. Blood 100:2175.
32. Zimmermann, U., Woenckhaus, C., Pietschmann, S. et al. 2004. Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch. 445:368.
33. Olwill, S. A., McGlynn, H., Gilmore, W. S. and Alexander, H. D. 2005. Annexin II cell surface and mRNA expression in human acute myeloid leukaemia cell lines. Thromb. Res. 115:109.
34. Menell, J. S., Cesarman, G. M., Jacovina, A. T., McLaughlin, M. A., Lev, E. A. and Hajjar, K. A. 1999. Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med. 340:994.
35. Brownstein, C., Falcone, D. J., Jacovina, A. and Hajjar, K. A. 2001. A mediator of cell surface-specific plasmin generation. Ann. N. Y. Acad. Sci. 947:143.
36. Takahashi, S., Reddy, S. V., Chirgwin, J. M. et al. 1994. Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J. Biol. Chem. 269:28696.
37. Menaa, C., Devlin, R. D., Reddy, S. V., Gazitt, Y., Choi, S. J. and Roodman, G. D. 1999. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J. Clin. Invest. 103:1605.
38. Donato, R. 2001. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33:637.
39. Weterman, M. A., Stoopen, G. M., van Muijen, G. N., Kuznicki, J., Ruiter, D. J. and Bloemers, H. P. 1992. Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res. 52:1291.
40. Komatsu, K., Andoh, A., Ishiguro, S. et al. 2000. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin. Cancer Res. 6:172.
41. Vimalachandran, D., Greenhalf, W., Thompson, C. et al. 2005. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res. 65:3218.
42. Cross, S. S., Hamdy, F. C., Deloulme, J. C. and Rehman, I. 2005. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46:256.
43. Breen, E. C. and Tang, K. 2003. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J. Cell. Biochem. 88:848.
44. Filipek, A. 2006. S100A6 and CacyBP/SIP - two proteins discovered in Ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin. Chemotherapy 52:32.